Beta-amyloid peptide binds equivalently to binary and ternary alpha2-macroglobulin-protease complexes

Area of Science:

• Biochemistry
• Molecular Biology
• Proteomics

Background:

• alpha2-Macroglobulin (alpha2M) is a key protease inhibitor.
• alpha2M has distinct binding sites for transforming growth factor-beta (TGF-beta) and beta-amyloid peptide (Abeta).
• TGF-beta binding to alpha2M is sterically hindered by proteases within the central cavity.

Purpose of the Study:

• To investigate if beta-amyloid peptide (Abeta) binding to alpha2-Macroglobulin (alpha2M) is affected by protease association.
• To compare the binding characteristics of Abeta and TGF-beta to alpha2M in the presence of proteases.

Main Methods:

• Studied alpha2M binding of TGF-beta1 and Abeta in the presence of varying amounts of trypsin.
• Analyzed Abeta binding to alpha2M-plasmin complexes, noting plasmin's large size and cavity occupancy.

Main Results:

• alpha2M-trypsin complexes showed altered TGF-beta1 binding, with binary complexes binding more and ternary complexes binding less.
• Abeta binding to alpha2M was significantly increased in the presence of trypsin, regardless of protease load.
• alpha2M-plasmin complexes also exhibited enhanced Abeta binding compared to native alpha2M.

Conclusions:

• beta-amyloid peptide (Abeta) binding to alpha2-Macroglobulin (alpha2M) is not sterically constrained by proteases in the central cavity.
• Abeta likely accesses its binding site on alpha2M from outside the central cavity.
• The binding sites for TGF-beta and Abeta on alpha2M are spatially distinct in both sequence and structure.